HSA — authorised 7 July 2020
- Marketing authorisation holder: OTSUKA
- Status: likely_approved
HSA authorised Inqovi on 7 July 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 7 July 2020.
OTSUKA holds the Singaporean marketing authorisation.